Fulcrum Phase 3 FSHD Clinical Trial using AMRA Medical’s Whole-body MRI Measurements as a Key Secondary Endpoint
REACH, a Phase 3 Clinical Trial of losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) utilizes AMRA's Muscle Fat Infiltration…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Jul 22
REACH, a Phase 3 Clinical Trial of losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) utilizes AMRA's Muscle Fat Infiltration…
14 Jul 22
As the first self-expanding TPVR product approved for marketing in both China and Europe, VenusP-ValveTM sets itself apart…
13 Jul 22
The company designed AccuCinch System to provide a minimally invasive transcatheter therapy for patients living with symptomatic heart…
13 Jul 22
The solution is claimed to be the first and only machine-learning algorithm to help healthcare professionals in detecting…
13 Jul 22
The FFRangio System uses AI to give diagnostic and physiological data, which can challenge conventional FFR and change…
13 Jul 22
The Breakthrough Device Designation will allow Abbott to make available the deep brain stimulation System as a new…
13 Jul 22
Fluke Biomedical OneQA automates a selection of Fluke Biomedical tools which now includes the ProSim 8. OneQA can…
13 Jul 22
As first test to receive FDA clearance across all current iOS and Android smartphone devices, Minuteful Kidney holds…
12 Jul 22
Hologic is commercialising its Panther Fusion SARS-CoV-2/Flu A/B/RSV assay, and Novodiag RESP-4 assay, while Thermo Fisher is rolling…
12 Jul 22
The technology enables Smith+Nephew to provide technical support for the safe and efficient usage of its products at…